Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rubella vaccine--how 'reactogenic' is it?

G V Griffin, K A Bryett

    The Journal of International Medical Research
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    This study evaluated two rubella vaccines in girls aged 11-13, finding minor side effects but no significant differences between vaccine types. Rubella vaccination in the UK offers a favorable risk-benefit profile.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants.

    Public health·1989
    Same author

    An evaluation of diphtheria--tetanus (adult) vaccine in unselected human volunteers.

    The Journal of international medical research·1989
    Same author

    Diphtheria and tetanus vaccine: a comparative study of reactogenicity.

    The British journal of clinical practice·1989
    Same author

    Incidence of reactions to meningococcal A&C vaccine among U.K. schoolchildren.

    Public health·1988
    Same author

    Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity.

    Blood·1987
    Same author

    Influenza vaccination in a boarding school population.

    The British journal of clinical practice·1987

    Area of Science:

    • Pediatrics
    • Immunology
    • Public Health

    Background:

    • Rubella infection poses risks, particularly for pregnant women, necessitating effective vaccination strategies.
    • The RA27/3 rubella vaccine is a widely used live attenuated vaccine.
    • Assessing vaccine safety and efficacy in target populations is crucial for public health initiatives.

    Purpose of the Study:

    • To compare the reactogenicity and safety of two different RA27/3 rubella vaccine preparations.
    • To evaluate the risk-benefit ratio of rubella vaccination in adolescent girls within the UK context.

    Main Methods:

    • A randomized controlled trial involving 231 girls aged 11-13 years.
    • Administration of one of two RA27/3 rubella vaccine formulations (Institut Merieux vs. Wellcome).

    Related Experiment Videos

  • Intensive follow-up to monitor for and document all reported side effects.

    • Main Results:

    • A high incidence of minor, self-limiting side effects was observed in the study population.
    • No statistically significant differences in reactogenicity were detected between the two vaccine preparations.
    • The overall safety profile of both rubella vaccines was deemed acceptable.

    Conclusions:

    • Both RA27/3 rubella vaccines demonstrated a favorable safety profile with manageable side effects.
    • The study supports the established efficacy and safety of rubella vaccination programs.
    • Rubella vaccination in the UK presents a highly acceptable risk-benefit ratio for the targeted age group.